COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 15. Feb. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HAMILTON MATTHEW J [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-02-15, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
US2024050489 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA000660485 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA000660485 | ||
| 003 | DE-627 | ||
| 005 | 20240329155313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA000660485 | ||
| 035 | |a (EPA)US2024050489 | ||
| 035 | |a (EPA)67541903 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HAMILTON MATTHEW J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-02-15, Last update posted on www.tib.eu: 2024-03-20, Last updated: 2024-03-29 | ||
| 520 | |a The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a A01N: Preservation of bodies of humans or animals or plants or parts thereof (preservation of food or foodstuff a23); biocides, e.g. as disinfectants, as pesticides or as herbicides (preparations for medical, dental or toilet purposes which kill or prevent the growth or proliferation of unwanted organisms a61k); pest repellants or attractants; plant growth regulators | |
| 650 | 4 | |a che | |
| 650 | 4 | |a hor | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a KHORUTS ALEXANDER |4 aut | |
| 700 | 0 | |a SADOWSKY MICHAEL J |4 aut | |
| 700 | 0 | |a STALEY CHRISTOPHER M |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 15. Feb. |
| 773 | 1 | 8 | |g year:2024 |g day:15 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/67541903/publication/US2024050489A1?q=US2024050489 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 15 |c 02 | ||